Monogram Biosciences, Inc., is a leader in developing and commercializing innovative diagnostic products to help guide and improve the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. Monogram’s services enable health care providers to optimize treatment regimens for their patients. We also support pharmaceutical companies in developing new and improved antiviral therapeutics and vaccines and targeted cancer therapeutics.
Monogram Biosciences is a member of the LabCorp Specialty Testing Group. It was founded in South San Francisco in 1995 and became a wholly-owned subsidiary of LabCorp in 2009. Monogram is a leading commercial company that performs HIV phenotypic testing. Our clinical reference lab is fully CAP and CLIA accredited.
Monogram provides testing for clinical patient management and drug/vaccine development, and supports clinical trials directly and as part of the Covance Drug Development team. To date, Monogram scientists have published more than 200 articles in peer-reviewed journals.